Pterostilbene attenuates cisplatin-induced acute kidney injury by suppressing TLR4/MyD88/NF-κB signaling.
Cisplatin-induced acute kidney injury (Cis-AKI) is a common and severe dose-limiting complication of cisplatin-based chemotherapy, and effective preventive or therapeutic strategies remain limited. Pterostilbene (PTE), a naturally occurring polyphenolic compound, exhibits potent anti-inflammatory and antioxidant proper...